BioRestorative Therapies, Inc. (BRTX) stock
BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$1.49−0.01 (-0.67%)
Close on Nov 13, 2026Market cap $37.96MP/E –Yield –
BioRestorative Therapies profit margin
Profit margin (net margin) is net income as a percentage of revenue.
BioRestorative Therapies's profit margin for the twelve months ending Mar 31, 2026 was -3089.6%. For fiscal 2025 it was -3959.4%, against -2239.2% the year before. The highest annual figure on record is -1259.9% in fiscal 2015.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3959.4% | −1720.2 |
| FY2024 | Dec 31, 2024 | -2239.2% | +4906.0 |
| FY2023 | Dec 31, 2023 | -7145.2% | +3891.8 |
| FY2022 | Dec 31, 2022 | -11037.0% | +85274.5 |
| FY2021 | Dec 31, 2021 | -96311.5% | −81671.7 |
| FY2020 | Dec 31, 2020 | -14639.9% | −3372.2 |
| FY2019 | Dec 31, 2019 | -11267.6% | +9.7 |
| FY2018 | Dec 31, 2018 | -11277.3% | +382.8 |
| FY2017 | Dec 31, 2017 | -11660.1% | +12095.4 |
| FY2016 | Dec 31, 2016 | -23755.4% | −22495.6 |
| FY2015 | Dec 31, 2015 | -1259.9% | +83.3 |
| FY2014 | Dec 31, 2014 | -1343.2% | +340989.8 |
| FY2013 | Dec 31, 2013 | -342333.0% | −300401.3 |
| FY2012 | Dec 31, 2012 | -41931.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -9298.3% | +12060.9 |
| Q4 FY2025 | Dec 31, 2025 | -16365.5% | −12586.9 |
| Q3 FY2025 | Sep 30, 2025 | -25748.1% | −25280.9 |
| Q2 FY2025 | Jun 30, 2025 | -875.8% | +3645.6 |
| Q1 FY2025 | Mar 31, 2025 | -21359.2% | −15007.0 |
| Q4 FY2024 | Dec 31, 2024 | -3778.6% | +8159.2 |
| Q3 FY2024 | Sep 30, 2024 | -467.2% | −15999.0 |
| Q2 FY2024 | Jun 30, 2024 | -4521.4% | +4330.4 |
| Q1 FY2024 | Mar 31, 2024 | -6352.2% | +16563.4 |
| Q4 FY2023 | Dec 31, 2023 | -11937.8% | +60184.9 |
| Q3 FY2023 | Sep 30, 2023 | 15531.8% | +34313.0 |
| Q2 FY2023 | Jun 30, 2023 | -8851.8% | −13212.1 |
| Q1 FY2023 | Mar 31, 2023 | -22915.6% | +28380.4 |
| Q4 FY2022 | Dec 31, 2022 | -72122.6% | +335940.1 |
| Q3 FY2022 | Sep 30, 2022 | -18781.2% | +33521.7 |
| Q2 FY2022 | Jun 30, 2022 | 4360.3% | +31444.2 |
| Q1 FY2022 | Mar 31, 2022 | -51296.0% | +35666.9 |
| Q4 FY2021 | Dec 31, 2021 | -408062.8% | −374172.7 |
| Q3 FY2021 | Sep 30, 2021 | -52302.9% | −46727.8 |
| Q2 FY2021 | Jun 30, 2021 | -27084.0% | −42219.0 |
| Q1 FY2021 | Mar 31, 2021 | -86962.9% | −57921.5 |
| Q4 FY2020 | Dec 31, 2020 | -33890.1% | −29044.6 |
| Q3 FY2020 | Sep 30, 2020 | -5575.1% | +7732.7 |
| Q2 FY2020 | Jun 30, 2020 | 15135.1% | +28545.3 |
| Q1 FY2020 | Mar 31, 2020 | -29041.4% | −15651.2 |
| Q4 FY2019 | Dec 31, 2019 | -4845.5% | +7466.4 |
| Q3 FY2019 | Sep 30, 2019 | -13307.8% | −2056.8 |
| Q2 FY2019 | Jun 30, 2019 | -13410.3% | −3911.8 |
| Q1 FY2019 | Mar 31, 2019 | -13390.2% | −192.0 |
| Q4 FY2018 | Dec 31, 2018 | -12311.9% | −7418.2 |
| Q3 FY2018 | Sep 30, 2018 | -11251.0% | +1574.5 |
| Q2 FY2018 | Jun 30, 2018 | -9498.4% | +4237.5 |
| Q1 FY2018 | Mar 31, 2018 | -13198.2% | +26598.3 |
| Q4 FY2017 | Dec 31, 2017 | -4893.8% | +28960.9 |
| Q3 FY2017 | Sep 30, 2017 | -12825.6% | +23852.0 |
| Q2 FY2017 | Jun 30, 2017 | -13735.9% | +243.8 |
| Q1 FY2017 | Mar 31, 2017 | -39796.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -33854.7% | – |
| Q3 FY2016 | Sep 30, 2016 | -36677.6% | – |
| Q2 FY2016 | Jun 30, 2016 | -13979.7% | – |
See a number that looks wrong?